Carl Quintanilla, Jim Cramer and David Faber took a wide-ranging look at the reopening trade: Uber shares under pressure after the company reported a revenue miss, vaccine makers such as Pfizer, BioNTech and Moderna saw their shares take a hit after the Biden Administration announced that it supports waiving intellectual property protections for COVID-19 vac ... Show More
May 2021
The “DarkSide” of the Pipeline Shutdown; Dogecoin’s Nosedive; Hiring Slowdown
The United States’ largest fuel pipeline has been shut down since Friday after a cyber attack, and it’s not clear how long the outage will last. CNBC’s Brian Sullivan reports that the outage could lead to spot shortages of gas, diesel, and jet fuel, and CNBC’s Eamon Javers detail ... Show More
34m 43s
Feb 2023
CNBC Special Report: Taking Stock 2/14/23
<p>CNBC’s Frank Holland has your post-CPI playbook. Bleakley Advisory Group’s Peter Boockvar discusses the hotter-than-expected CPI report and what it means for the Fed going forward. David Steinberg, co-founder and CEO of Zeta Global, a data-driven cloud marketing company, discu ... Show More
44m 51s
Jun 2019
Surveillance: Trade Talks Are Unpredictable, Hewson Says
David Page, AXA Investment Managers U.S. & U.K. Senior Economist, says there is a small risk of a Fed cut in two weeks. Stephanie Baker, Bloomberg News Senior Writer, updates us on trade negotiations between the U.S. and Mexico. Victoria Hewson, Institute of Economic Affairs Seni ... Show More
30m 12s
May 2022
Upstart CEO, Biohaven Pharma CEO, Crocs CEO & Sysco CEO 5/10/22
The Dow continued to move lower while the S&P 500 and Nasdaq rose, and Jim Cramer is taking you through the day’s action. Then, after Upstart fell 56% today and CEO Dave Girouard sits down to break down yesterday's earnings and find out what sent the stock tumbling. And, Pfizer a ... Show More
44m 46s
Sep 2020
Eli Lilly CEO, Coca Cola CEO & Albertsons CEO
<p>The Dow was down 942 points at its session lows in a September-style selloff to start the week and Jim Cramer is helping investors navigate the day’s volatility. Then, as pharmaceutical companies focus on COVID-19, Eli Lilly CEO Dave Ricks checks in to discuss the company's pr ... Show More
46m 19s